MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3233/hab-140280

Медицинская библиотека · Human antibodies · 2014

Novel antiphospholipid antibodies in autoimmune bullous diseases.

Sagi Lior, Baum Sharon, Barzilai Ori, Ram Maya, Bizzaro Nicola, SanMarco Marielle, Shoenfeld Yehuda, Sherer Yaniv

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Pemphigus and bullous pemphigoid are two autoimmune diseases that have similar pathogenesis. Both have a genetic predisposition, which promotes the production of auto antibodies targeted against different components of the epidermal desmosome and hemidesmosome. Antiphospholipid antibodies (aPL) are heterogeneous group of antibodies found in patients with autoimmune diseases and inflammatory conditions and are associated with thrombotic events.

OBJECTIVE

We sought to determine the expression profile of eight non classical aPLs in ABD patients.

METHODS

A cohort of 266 serum samples of patients with pemphigus, bullous pemphigoid and controls was screened for the presence of eight aPL antibodies, using the Bio-Rad BioPlex™ 2200 system.

RESULTS

Phosphatidylserine-beta-2-glycoprotein-I (aPS-β2GPI) and anti prothrombin complex (aPT-PT) serum profiles were significantly more prevalent among ABD patients; 20.7% patients with ABD compared to 5.9% of control patients were positive for aPS-β2GPI IgM. In addition, aPT-PT IgM was more prevalent among ABD patients (31% vs. 14.8%).

CONCLUSION

aPL auto antibodies are more prevalent in ABD. Any clinical association should be further determined.

Для цитирования: Sagi Lior, Baum Sharon, Barzilai Ori, Ram Maya, Bizzaro Nicola, SanMarco Marielle, Shoenfeld Yehuda, Sherer Yaniv. Novel antiphospholipid antibodies in autoimmune bullous diseases.. Human antibodies. 2014. DOI: 10.3233/hab-140280.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.